Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Miles Adalat CC pharmacist counseling program

Executive Summary

Company agrees to pay $200,000 to Massachusetts under an agreement with state attorney general's office over payments made to pharmacists for prescriptions covered under the state Medicaid program. Miles admits no wrong-doing in connection with "cognitive services program" that provided pharmacists with $35 compensation payment for counseling services to patients who presented new Adalat CC (once-daily nifedipine) prescriptions. Miles previously settled with 11 state attorneys general, including Massachusetts, over privacy and restraint of trade issues raised by the discontinued program ("The Pink Sheet" April 11, p. 3)

Latest Headlines
See All
UsernamePublicRestriction

Register

PS024709

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel